Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock

All NewsApril 21, 2026

Danaher Q1 earnings beat estimates as bioprocessing drives growth, while diagnostics weakens, and the respiratory outlook is lowered.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Walmart is selling top-rated Swarovski hoop earrings that come in 3 colors for just $21

Heads up: US bond market closed for Veterans Day as stocks face a hot CPI hangover

Amazon’s bestselling metal storage shed with lockable doors is only $110

How Singapore became a linchpin of China’s AI chip trade

Anthropic IPO valuation calculator: How much is it really worth?